FDC Ltd Recalls Thousands of Glaucoma Medication Bottles Due to Defective Packaging

FDC Ltd, a Mumbai-based pharmaceutical company, is recalling more than 60,000 bottles of a generic glaucoma medication from the US market, the US Food and Drug Administration (USFDA) reports.

The recall affects 60,428 bottles of Timolol Maleate Ophthalmic Solution due to defective containers, where the spike of the cap is obstructing the nozzle. This renders the solution inaccessible for patients.

The recall, classified as Class II nationwide in the US, began on April 18. A Class II recall indicates potential temporary or medically reversible adverse health consequences, or where serious consequences are unlikely.

(With inputs from agencies.)